NXT007 not checked

Roche · RO7589655 · RG6512

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
4 active
5 in total · 3 in the EU
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“NXT007 will be administered subcutaneously (SC) using an integrated drug-device combination product.”In the company’s words, NCT07416526 on ClinicalTrials.gov
Tested for
Hemophilia A (4 trials)
Main trialPhase 3
“The purpose of this study is to evaluate the efficacy, safety, pharmacokinetics and pharmacodynamics of NXT007 prophylaxis compared with Factor VIII (FVIII) prophylaxis in participants with severe or moderate congenital hemophilia A without FVIII inhibitors. The study will include people aged ≥12 years old who have been on FVIII prophylaxis treatment prior to study entry.”In the company’s words, NCT07416526 on ClinicalTrials.gov
Other names
RO7589655 · Zemocimig · RG6512

Other drugs for Hemophilia A

All 26 drugs for Hemophilia A

Coming up4

Changes1

Last 90 days

Trials5

TrialPhaseCompletesWhat it tests
Phase 3Recruiting 23 Sep 2027 A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
Phase 3Recruiting 29 Feb 2028 A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
Phase 3Recruiting 30 Sep 2028 Clinical Trial of NXT007 for the Prophylactic Treatment of Hemophilia A in Infants and Children
Phase 1/2Recruiting 11 Dec 2033 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
Phase 1Completed 22 Dec 2024 A Study to Evaluate Single Subcutaneous Doses of NXT007 Among Injection Sites Abdomen, Upper Arm, and Thigh in Healthy Male Participants
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow NXT007

Following is part of Solo: you see every change to NXT007 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in